Carboprost

This classification denotes a prostaglandin analogue with the molecular formula C21H36O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B5032XT6O, chemically known as 9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oic acid (5z,9alpha,11alpha,13e,15s)- but generally known as carboprost, which bears US NIH Compound Identifier 5281005. Carboprost most often comes in base, methyl, methyl ester, and tromethamine forms. European Medicines Agency schedules Carboprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06615MIG. The term CARBOPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules carboprost in its Anatomical Therapeutic Chemical (ATC) Classification. CARBOPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carboprost under HS 29375000 and SITC 54156. As of Q4 2014, CARBOPROST remains the US FDA Preferred Term for this commodity. Carboprost bears US NLM identifiers UMLS ID C0007047 and NCI Concept Code C61662. SMILES: OC1C(C(C(O)C1)/C=C/C(O)(CCCCC)C)C/C=C\CCCC(=O)O.